About LifeArc
LifeArc is a self-funded medical research charity collaborating with partners to make medical breakthroughs. They ensure that promising science achieves its potential, delivering impactful outcomes for patients, faster.
The team at LifeArc have identified areas with under-served healthcare needs – motor neuron disease, chronic respiratory infection, global health, rare disease, and childhood cancer – where their expertise in translational science can help the most. They call these ‘Translational Challenges’ and collaborate with others already working in those areas to create better diagnostics and treatments by providing investment, expert scientific support and commercialisation advice.
Working with UK DRI
In 2022, LifeArc committed £30M in a new partnership with the UK DRI. A total of £14.5M has been allocated thus far to support seven innovative projects seeking to develop new tests, treatments and medical devices for the more than one million people in the UK living with neurodegenerative conditions including Alzheimer’s disease, motor neuron disease, frontotemporal dementia and Parkinson’s disease. The exciting projects range from repurposing existing drugs, to developing brand new therapeutic targets.
As well as translational award rounds, UK DRI scientists benefit from world-leading technology transfer and translational science expertise and access to LifeArc’s therapeutic and diagnostic/antibody platforms. These expertise and services help move research further down the discovery pipeline, making projects less risky and more attractive to future partners, such as pharmaceutical companies, who can take them into clinical trials needed to develop new treatments.
Latest news
